Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Dedication: Robert Austrian | |
History | |
The History of Pneumococcal Disease | p. 3 |
History of Pneumococcal Immunization | p. 19 |
Biological Basis | |
Genetics, Biosynthesis, and Chemistry of Pneumococcal Capsular Polysaccharides | p. 33 |
Animal Models of Invasive Pneumococcal Disease | p. 47 |
Animal Models of Pneumococcal Colonization | p. 59 |
The Immunobiology of Polysaccharide and Conjugate Vaccines | p. 67 |
Interactions of Streptococcus pneumoniae with Complement Proteins | p. 83 |
Clinical Disease and Epidemiology | |
Epidemiology, Diagnosis, and Treatment of Serious Pneumococcal Infections in Children | p. 95 |
Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy | p. 117 |
Pneumococcal Serotype Epidemiology | p. 139 |
Manufacturing and Product Release Issues | |
Conjugation Chemistry | p. 163 |
Pneumococcal Vaccines: Manufacture and Quality Control for Product Release | p. 175 |
Licensing of Pneumococcal Conjugate Vaccines for Children and Adults: Regulatory Perspective from the European Medicines Agency and the U.S. Food and Drug Administration | p. 183 |
Immunogenicity | |
Quantitation of Anti-Pneumococcal Capsular Antibody in Ligand-Binding Assays | p. 199 |
Functional Assays for Pneumococcal Antibody | p. 213 |
Immunogenicity and Reactogenicity of Pneumococcal Conjugate Vaccines in Infants and Children | p. 227 |
Immunogenicity and Safety in Adults | p. 245 |
Immunogenicity in High-Risk and Immunocompromised Children and Adults | p. 261 |
Efficacy and Safety | |
Nasopharyngeal Carriage | p. 279 |
Acute Otitis Media and Its Sequelae | p. 301 |
Meta-Analysis of the Efficacy of Conjugate Vaccines against Invasive Pneumococcal Disease | p. 317 |
Efficacy and Safety of Conjugate Pneumococcal Vaccine in the Prevention of Pneumonia | p. 327 |
Establishing Immune Correlates of Protection | p. 339 |
Public Health Impact | |
Direct and Indirect Effectiveness and Safety of Pneumococcal Conjugate Vaccine in Practice | p. 353 |
Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance | p. 369 |
Pharmacoeconomics of Pneumococcal Conjugate Vaccines | p. 387 |
Opportunities and Challenges for Pneumococcal Conjugate Vaccines in Low- and Middle-Income Countries | p. 405 |
Where Next | |
Protein Vaccines | p. 421 |
Conclusions | p. 437 |
Index | p. 441 |
Table of Contents provided by Blackwell. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.